Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CINC424A2401

Abstract

Realization of a part of clinical trial called An open-label, multicenter, expanded access study of INC 424 for patients with primary myelofirosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelofibrisis (PET-MF)

Keywords

• INC424
• myelofibrosis